CEFEPIME

SynDRA canonical compound SYN0006741 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	A1BG
Mechanism of action	bacterial cell wall synthesis inhibitor \| penicillin binding protein inhibitor
Indication	gram-negative bacterial infections \| intra-abdominal infections \| pneumonia \| skin infections \| urinary tract infections
Disease area	infectious disease \| Infectious disease

All known targets

cefepime dihydrochloride hydrate
cefepime hydrochloride
cefimen
tsefepim
cefepime HCl
Cefepima
BMY-28142
J01DE01
VNRX-5022
Renapime
Axepim
CFPM
Cefepimum
Cepimax
Cepimex
Maxcef
Maxipime
Cefepima [Spanish]
Cefepimum [Latin]
Axepim (TN)
Cefepime [USAN:INN]
Cepimax (TN)
Cepimex (TN)
Maxcef (TN)
Maxipime (TN)
Cefepime (USAN/INN)
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime)
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-[(1-methylpyrrolidinium-1-yl)methyl]-3,4-didehydrocepham-4-carboxylate
BMY 28142
CHEBI:478164
BMY28142
cefepim
RefChem:57263
DTXCID20820707
J01DA24
C19H24N6O5S2